Clinical trial
2-Hydroxybenzylamine: Initial Evaluation in Humans
NCT03176940 is registered in ClinicalTrials.gov with Metabolic Technologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 2-Hydroxybenzylamine: Initial Evaluation in Humans
- Lead sponsor
- Metabolic Technologies Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 2, 2017
- Completion date
- April 30, 2018
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers